Skip to main content
. 2015 Jan 28;10(1):e0117143. doi: 10.1371/journal.pone.0117143

Table 1. Sociodemographic, clinical and laboratory characteristics of participants (n = 798).

Age (year) mean ± std 59 ± 8
Male n (%) 676 (84.7)
Body Mass Index (kg/m2) mean ± std 27.0 ± 3.5
Body Mass Index n (%)
Normal weight 221 (27.7)
Overweight 443 (55.5)
Obese 134 (17)
Smoking n (%)
Never smoker 262 (32.8)
Ex-smoker 505 (63.3)
Current smoker 31 (3.9)
History of Myocardial Infarction n (%) 405 (50.8)
Coronary Artery Bypass Graft n (%) 395 (49.5)
History of Diabetes n (%) 129 (16.2)
Left Ventricular Function n (%)
Normal 434 (54.4)
Mild depression 196 (24.6)
Moderate depression 122 (15.3)
Severe depression 46 (5.8)
Systolic Blood Pressure (mmHg) mean ± std 120 ± 15
Diastolic Blood Pressure (mmHg) mean ± std 73 ± 9
Blood Pressure a n (%)
0 points 522 (65.4)
1 point 133 (16.7)
2 points 129 (16.2)
3 points 14 (1.8)
Time to blood withdrawal median, (Q1, Q3) 43 (36, 52)
Total Cholesterol (mg/dl) mean ± std 168 ± 32
HDL Cholesterol (mg/dl) mean ± std 40 ± 11
NT-proBNP at baseline (pg/mL) median, (Q1, Q3)
Female 690.2 (357.7, 1644)
Male 542.5 (277.6, 1043.5)
NT-proBNP at one year follow-up (pg/mL) median, (Q1, Q3)
Female 270 (115, 491)
Male 179.5 (87.4, 373.5)

a according to FRS chart for 10 years risk for CHD.